We comprehensively reveal the oncogenic role of IGF2BP2 in pancreatic cancer carcinogenesis and confirm that genomic amplification and the silencing of miR-141 contribute to its activation. The gene discussed is IGF2BP2; the disease is pancreatic neoplasm.